Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ROTOP Pharmaka is a leading German pharmaceutical company specializing in the development, manufacturing, and commercialization of cGMP-compliant radiopharmaceuticals for nuclear medicine and molecular imaging. The company has over 20 years of experience and distributes its products in more than 40 countries. Its portfolio includes sterile cold kits for radiolabelled drugs, ready-to-use radiopharmaceuticals, and contract manufacturing services. Notably, RoTecPSMA®, a technetium‑99m cold kit for SPECT imaging of prostate cancer patients, recently received marketing authorization in the UK as the first PSMA-SPECT tracer approved in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ROTOP Pharmaka.